Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA
ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA
ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA
Submitted by
admin
on October 1, 2011 - 12:48pm
Source:
Yahoo/PR NewsWire
News Tags:
Adventrx
Exelbine
non-small cell lung cancer
Headline:
ADVENTRX Announces Results of FDA Meeting to Discuss Exelbine NDA
Do Not Allow Advertisers to Use My Personal information
